Hepatocellular Cancer
Overview
Hepatocellular cancer has been rising in the US due to the increase in Hepatitis B and C infections. Cirrhotic patients have a 3% a year risk of developing this. Symptoms include abdominal pain, fatigue, weight loss, or palpable mass, Diagnosis usually an ultrasound or CT with a biopsy. Alpha fetoprotein is elevated in 85%.
Treatment Options
Treatment options include surgery, chemoembolization, transplant, radiofrequency ablation, radiation, cryosurgery, or chemotherapy. Chemotherapy agents include Sorafenib.
Hepatocellular Cancer Specialists
Dr. Raymond Tsao
Dr. Tsao is board certified in medical oncology and hematology. He is currently seeing patients with all types of cancer, with a focus on hematologic and gastrointestinal malignancies, including esophageal, stomach, colorectal and pancreatic cancer. Dr. Tsao is a member of the American Society of Clinical Oncology and American Society of Hematology.
Dr. Vijay Narendran
Dr. Narendran is board certified in medical oncology and hematology. Dr. Narendran treats a variety of cancers and has a special interest in gastrointestinal and hematologic malignancies. Dr. Narendran is a member of the American Society of Clinical Oncology and the American Society of Hematology.
Kelly Foster, MD
Dr. Foster is board certified in medical oncology, internal medicine and palliative medicine. She is currently seeing patients with all types of cancer, with a focus on breast and gastrointestinal cancers (gastric, esophageal, pancreatic, hepatobiliary, colon, anal). She is a member of the American Society of Clinical Oncology.
